AJTMH ASTMH Job Mart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 69(5 suppl), 2003, pp. 11-17
Copyright © 2003 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MABEY, D.
Right arrow Articles by SOLOMON, A. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MABEY, D.
Right arrow Articles by SOLOMON, A. W.

APPLICATION OF MOLECULAR TOOLS IN THE CONTROL OF BLINDING TRACHOMA

DAVID MABEY AND ANTHONY W. SOLOMON
Clinical Research Unit, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom

The use of anti-chlamydial antibiotics for trachoma control is based on the assumption that most people with clinically active disease have conjunctival infection with Chlamydia trachomatis. In high prevalence areas, this is generally true. As prevalence decreases, however, the positive predictive value of clinical signs for C. trachomatis infection also decrease. In this paper, the case for using laboratory assays to guide trachoma control strategies is presented, molecular methods for diagnosis (such as a ligase chain reaction and a polymerase chain reaction [PCR]) are compared with earlier techniques, and recent findings of ongoing studies using a quantitative PCR are reviewed. In addition, the contribution of genotyping to our understanding of the epidemiology and biology of C. trachomatis is considered.


Received July 30, 2003. Accepted for publication September 2, 2003.

Financial support: Anthony W. Solomon is supported at the London School of Hygiene and Tropical Medicine by the International Trachoma Initiative (grant #01-034). This work was supported by the International Trachoma Initiative, the Wellcome Trust/ Burroughs Wellcome Fund, and the Medical Research Council, United Kingdom.

Authors’ address: David Mabey and Anthony W. Solomon, Clinical Research Unit, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, United Kingdom., Telephone: 44-20-7927-2256, Fax: 44-20-7637-4314, E-mail: david.mabey{at}lshtm.ac.uk.




This article has been cited by other articles:


Home page
Am J Trop Med HygHome page
M. Porter, D. Mak, G. Chidlow, G. B. Harnett, and D. W. Smith
The Molecular Epidemiology of Ocular Chlamydia trachomatis Infections in Western Australia: Implications for Trachoma Control
Am J Trop Med Hyg, March 1, 2008; 78(3): 514 - 517.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
A. W. Solomon, R. W. Peeling, A. Foster, and D. C. W. Mabey
Diagnosis and Assessment of Trachoma
Clin. Microbiol. Rev., October 1, 2004; 17(4): 982 - 1011.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Society of Tropical Medicine and Hygiene.